Henry Meds vs TrimRx: Cheapest Compounded GLP-1 vs Safest
Henry Meds is the cohort's price leader on compounded oral semaglutide and a rare source of oral tirzepatide tablets. TrimRx is the cohort's trust leader on compounded GLP-1, with a strong accreditation stack and a clean regulatory record. The honest framing is that this comparison is not really close on trust posture, but the price gap is real for cost-sensitive readers.
Henry Meds
2.7Cohort-cheapest compounded GLP-1, with the cohort-worst trust signals
TrimRx
4.3LegitScript-certified compounded GLP-1 telehealth
Reviewed by Designing Longevity Editorial·Last verified May 1, 2026
Bottom line
For most readers, TrimRx is the right answer. The trust signals against Henry Meds are unusually heavy: BBB F rating with 25 unanswered complaints, a Trustpilot suspected-fraudulent-review notice on the company profile page, and an active Eli Lilly lawsuit on compounded-tirzepatide marketing that survived a partial dismissal. Choose Henry Meds only if pure cash price is the binding constraint AND you are going in eyes wide open on the trust caveats AND you specifically want a product line TrimRx doesn't offer (oral tirzepatide tablets).
Side-by-side at a glance
Who wins for each use case
We pick a winner per criterion and explain the reasoning. Skip to whichever rows match how you'd actually use the platform.
Cash-pay price on oral semaglutide
Winner: Henry MedsHenry Meds starts oral semaglutide around $99/month, which is materially below TrimRx and the rest of the cohort. If pure headline price is the only thing you weight, this is the cheapest option that exists. The caveat is that BBB complaints describe a secondary $49/month subscription disclosed only in the terms of service, so the all-in monthly cost can be higher than the headline.
BBB rating and complaint posture
Winner: TrimRxTrimRx is BBB Accredited with a B rating. Henry Meds is NOT BBB-accredited and carries an F letter grade with 192 complaints in three years (25 of which received no business response). The non-response rate is the part that drove the F. This is the largest single trust gap in our cohort.
Trustpilot credibility
Winner: TrimRxHenry Meds shows 4.5/5 across roughly 12,300 reviews, but the page itself carries Trustpilot's suspected-fraudulent-review notice. That notice is Trustpilot's own flag that something about the review pattern looks artificial; we weight that flag more heavily than the average. TrimRx has no fraud notice on its profile.
Regulatory and legal record
Winner: TrimRxNeither has an FDA warning letter (verified vs the September 2025 and March 2026 enforcement rounds). Henry Meds has an active Eli Lilly lawsuit (4:25-cv-03536, N.D. Cal.) over compounded-tirzepatide marketing claims; the personalization-marketing claim survived a September 2025 partial dismissal. TrimRx has no comparable open litigation at capture date.
Accreditation stack
Winner: TrimRxTrimRx has the strongest accreditation stack in the compounded cohort: LegitScript Healthcare Merchant certification, BBB-accredited, partner pharmacies that are LegitScript-certified. Henry Meds has unconfirmed LegitScript on a public registry and no compensating accreditations to offset the BBB picture.
Oral tirzepatide tablet availability
Winner: Henry MedsHenry Meds offers oral tirzepatide tablets at $349/month month-to-month or $234/month on annual prepay, which is a relatively rare product line. Most compounded competitors only offer injectable tirzepatide. If you specifically want oral tirzepatide tablets, the choice narrows.
Cancellation friction
Winner: TrimRxHenry Meds requires a phone call to cancel; multiple BBB complaints describe unanswered calls and continued billing after attempted cancellation. TrimRx provides a documented in-app cancellation flow without comparable complaint volume. If frictionless cancellation matters, TrimRx wins outright.
Rubric scores side-by-side
Same six dimensions we use on every provider profile, weighted to a single 0-5 score. Click through to either profile for the verification details behind each row.
Licensure 20% weight
Accreditation 20% weight
Transparency 20% weight
Product quality 15% weight
Pricing 15% weight
Customer service 10% weight
Pricing in plain terms
The price gap is real on oral semaglutide (Henry Meds ~$99/month vs TrimRx ~$149+/month), but reading BBB complaints on Henry Meds suggests the all-in cost can be higher than the headline once the secondary $49/month subscription surfaces. TrimRx is competitive on injectable semaglutide and tirzepatide. For most cost-sensitive readers, TrimRx's slightly higher monthly cost buys a meaningfully cleaner trust posture; the trust premium is worth paying.
Read the full profiles
This comparison summarizes the head-to-head call. The full provider profiles include verification items, regulatory history, public-review aggregation, and the signup walkthrough.